US 11773156
Anti-hemagglutinin antibodies and methods of use thereof
granted A61KA61K39/395A61K39/42
Quick answer
US patent 11773156 (Anti-hemagglutinin antibodies and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K39/395, A61K39/42, A61K45/06, A61P